Assembly Biosciences (NASDAQ:ASMB) reported quarterly losses of $(1.17) per share which beat the analyst consensus estimate of $(1.60) by 26.88 percent. This is a 29.52 percent increase over losses of $(1.66) per share from the same period last year. The company reported quarterly sales of $9.42 million which beat the analyst consensus estimate of $7.63 million by 23.48 percent. This is a 62.82 percent increase over sales of $5.79 million the same period last year.